...
首页> 外文期刊>Cellular microbiology >First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites
【24h】

First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites

机译:利什曼原虫中第一个有效的CRISPR-Cas9介导的基因组编辑

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Protozoan pathogens that cause leishmaniasis in humans are relatively refractory to genetic manipulation. In this work, we implemented the CRISPR-Cas9 system in Leishmania parasites and demonstrated its efficient use for genome editing. The Cas9 endonuclease was expressed under the control of the Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) promoter and the single guide RNA was produced under the control of the U6snRNA promoter and terminator. As a proof of concept, we chose to knockout a tandemly repeated gene family, the paraflagellar rod-2 locus. We were able to obtain null mutants in a single round of transfection. In addition, we confirmed the absence of off-target editions by whole genome sequencing of two independent clones. Our work demonstrates that CRISPR-Cas9-mediated gene knockout represents a major improvement in comparison with existing methods. Beyond gene knockout, this genome editing tool opens avenues for a multitude of functional studies to speed up research on leishmaniasis.
机译:在人类中引起利什曼病的原生动物病原体相对难于遗传操作。在这项工作中,我们在利什曼原虫中实施了CRISPR-Cas9系统,并证明了其在基因组编辑中的有效利用。 Cas9核酸内切酶在二氢叶酸还原酶-胸苷酸合酶(DHFR-TS)启动子的控制下表达,单个指导RNA在U6snRNA启动子和终止子的控制下产生。作为概念的证明,我们选择剔除串联重复的基因家族,鞭毛杆2​​位点。我们能够在单轮转染中获得无效突变体。此外,我们通过两个独立克隆的全基因组测序证实了脱靶版本的存在。我们的工作表明,与现有方法相比,CRISPR-Cas9介导的基因敲除代表了一项重大改进。除基因敲除外,该基因组编辑工具还为众多功能研究开辟了途径,以加快对利什曼病的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号